PREDICTIVE VALUE OF FDG PET/CT IN PATIENTS WITH RELAPSE/REFRACTORY MULTIPLE MYELOMA BEFORE TREATMENT WITH ANTI‐CD38 IMMUNOTHERAPY

Authors :: Paul Deschamps
Patricia Franchi
A. Dechmi
L. Willems
A. Cottereau
J. Descroocq
Sylvain Barreau
Didier Bouscary
M. Wartski
G. Fouquet
Benedicte Deau-Fischer
N. Chapuis
J. Clerc
Marguerite Vignon
Source :: Hematological Oncology. 39
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Refractory Multiple Myeloma
Hematology
General Medicine
Immunotherapy
CD38
Predictive value
Oncology
medicine
In patient
Fdg pet ct
Radiology
business

Full Text Access

Tools